Principles in Management of Soft Tissue Sarcoma.
作者信息
Crago Aimee M, Brennan Murray F
机构信息
Sarcoma Disease Management Team, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
Sarcoma Disease Management Team, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
出版信息
Adv Surg. 2015;49(1):107-22. doi: 10.1016/j.yasu.2015.04.002. Epub 2015 May 5.
Abstract
摘要
相似文献
1
Principles in Management of Soft Tissue Sarcoma.
Adv Surg. 2015;49(1):107-22. doi: 10.1016/j.yasu.2015.04.002. Epub 2015 May 5.
2
Systemic therapy in retroperitoneal sarcoma management.
J Surg Oncol. 2018 Jan;117(1):87-92. doi: 10.1002/jso.24933. Epub 2017 Nov 30.
3
Management of localized extremity and retroperitoneal soft tissue sarcoma.
Curr Probl Cancer. 2019 Aug;43(4):273-282. doi: 10.1016/j.currproblcancer.2019.06.002. Epub 2019 Jun 15.
4
[Limb and retroperitoneal sarcomas: progress with an optimal multidisciplinary management].
Cancer Radiother. 2006 Feb-Mar;10(1-2):1-2. doi: 10.1016/j.canrad.2005.10.014. Epub 2006 Jan 27.
5
Singapore Cancer Network (SCAN) Guidelines for the Initial Evaluation, Diagnosis and Management of Retroperitoneal Soft Tissue Sarcoma.
Ann Acad Med Singap. 2015 Oct;44(10):484-91.
6
Current concepts in multimodality therapy for retroperitoneal sarcoma.
Expert Rev Anticancer Ther. 2007 Feb;7(2):159-68. doi: 10.1586/14737140.7.2.159.
7
Evolving Treatment of Soft Tissue Sarcoma.
J Natl Compr Canc Netw. 2017 May;15(5S):733-736. doi: 10.6004/jnccn.2017.0087.
8
Post-operative surveillance in retroperitoneal soft tissue sarcoma: The importance of tumor histology in guiding strategy.
J Surg Oncol. 2018 Jan;117(1):99-104. doi: 10.1002/jso.24927. Epub 2017 Nov 28.
9
[A case of retroperitoneal alveolar soft part sarcoma].
Gan No Rinsho. 1986 Jun;32(7):826-30.
10
Soft tissue sarcomas of the extremity and retroperitoneum: advances in management.
Adv Surg. 1991;24:333-59.
引用本文的文献
1
Curative endoscopic resection of giant esophageal dedifferentiated liposarcoma: a case report and literature review.
Front Med (Lausanne). 2025 Aug 26;12:1662503. doi: 10.3389/fmed.2025.1662503. eCollection 2025.
2
Pseudo-Pseudo Polyp: Spindle Cell Sarcoma at an Ileocolonic Anastomosis.
ACG Case Rep J. 2025 Aug 22;12(8):e01817. doi: 10.14309/crj.0000000000001817. eCollection 2025 Aug.
3
Untangling the Role of MYC in Sarcomas and Its Potential as a Promising Therapeutic Target.
Int J Mol Sci. 2025 Feb 25;26(5):1973. doi: 10.3390/ijms26051973.
4
Management Algorithm for Atypical Lipomatous Tumours: A Retrospective Case Series.
Cureus. 2025 Jan 13;17(1):e77384. doi: 10.7759/cureus.77384. eCollection 2025 Jan.
5
A Narrative Review of the Assessment and Treatment of Physical Impairments Commonly Seen in Sarcoma Cancer Survivors Using a Rehabilitative Approach.
Cancers (Basel). 2024 Dec 24;17(1):6. doi: 10.3390/cancers17010006.
6
Predicting progression-free survival in sarcoma using MRI-based automatic segmentation models and radiomics nomograms: a preliminary multicenter study.
Skeletal Radiol. 2025 Jul;54(7):1417-1427. doi: 10.1007/s00256-024-04837-7. Epub 2024 Dec 4.
7
Development and validation of a machine learning-based model to predict postoperative overall survival in patients with soft tissue sarcoma: a retrospective cohort study.
Am J Cancer Res. 2024 Oct 15;14(10):4731-4746. doi: 10.62347/ZQVY3877. eCollection 2024.
8
CFLAR: A novel diagnostic and prognostic biomarker in soft tissue sarcoma, which positively modulates the immune response in the tumor microenvironment.
Oncol Lett. 2024 Feb 14;27(4):151. doi: 10.3892/ol.2024.14284. eCollection 2024 Apr.
9
Giant atypical lipomatous tumors of the thigh: a case series.
Acta Biomed. 2023 Oct 17;94(5):e2023202. doi: 10.23750/abm.v94i5.14275.
10
Bilateral Renal Auto-Transplantation for Retroperitoneal Sarcomas: Is It Underutilized?
Curr Oncol. 2023 Aug 14;30(8):7620-7626. doi: 10.3390/curroncol30080552.
本文引用的文献
1
Lessons learned from the study of 10,000 patients with soft tissue sarcoma.
Ann Surg. 2014 Sep;260(3):416-21; discussion 421-2. doi: 10.1097/SLA.0000000000000869.
2
Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma.
J Clin Oncol. 2013 Jun 1;31(16):2024-8. doi: 10.1200/JCO.2012.46.5476. Epub 2013 Apr 8.
3
A prognostic nomogram for prediction of recurrence in desmoid fibromatosis.
Ann Surg. 2013 Aug;258(2):347-53. doi: 10.1097/SLA.0b013e31828c8a30.
4
Clinical outcomes and safety with trabectedin therapy in patients with advanced soft tissue sarcomas following failure of prior chemotherapy: results of a worldwide expanded access program study.
Ann Oncol. 2013 Jun;24(6):1703-9. doi: 10.1093/annonc/mds659. Epub 2013 Feb 5.
5
Myxofibrosarcoma: prevalence and diagnostic value of the "tail sign" on magnetic resonance imaging.
Skeletal Radiol. 2013 Jun;42(6):809-18. doi: 10.1007/s00256-012-1563-6. Epub 2013 Jan 15.
6
Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors.
Nat Genet. 2013 Feb;45(2):131-2. doi: 10.1038/ng.2522. Epub 2013 Jan 13.
7
Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing.
Nat Genet. 2013 Feb;45(2):180-5. doi: 10.1038/ng.2509. Epub 2013 Jan 13.
8
Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study.
Lancet Oncol. 2012 Nov;13(11):1133-40. doi: 10.1016/S1470-2045(12)70474-6. Epub 2012 Oct 17.
9
Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial.
Lancet Oncol. 2012 Oct;13(10):1045-54. doi: 10.1016/S1470-2045(12)70346-7. Epub 2012 Sep 4.
10
Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors.
Ann Surg Oncol. 2013 Jan;20(1):66-72. doi: 10.1245/s10434-012-2573-2. Epub 2012 Aug 10.
Zotero 插件